Restricted substances in manufacturing process

GECA·clause MS-2.5·pp.25-26

The requirement

The publisher’s words are shown on request, below the limits.

The publisher’s words

The publisher lets each reader see 3 of this document’s clauses a day.

This is the publisher’s condition for Klar Cite showing its words; the limits, the citation and everything else on this page are free to read. Showing the wording counts one clause.

How it is proven

Evidence required
A schedule of the constituent chemical substances in g/kg used in the manufacture of the product that are classified as harmful, and relevant SDS; A signed declaration from an Executive Director of the applicant company stating that the above compounds, their functional derivatives or in-situ precursors are not added to finished products, their component parts or used at any stage of the manufacturing process, including as preparatory agents, cleaners or degreasers in the production facility.
Who checks it
Applicant declares — a signed statement from the applicant

How Klar Cite classifies it

Klar Cite’s reading of the clause, not the scheme’s own claim.

What it asks
Meet — a limit, condition or outcome the product must satisfy
Standing
Required — must be met for the credential
Impact area
Human Health — the CMF area the clause addresses
Refers to
Appendix B; Table 1 — places elsewhere in the document

Cite this clause

GECA · Infant Mattress · version IM Gen 3.0 · clause MS-2.5 · page 25-26 · build 2026-10-05-0439 · https://klarcite.com/r/0668a145488fcbc2

Source document

Record details

Page 25-26. Read in build 2026-10-05-0439, harvested 2026-10-05.

uid 0668a145488fcbc2 · document 8eb27ed860c485d6 · fidelity verbatim · published 2026-06